nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.0373	0.0373	CcSEcCtD
Gadoteridol—Injection site pain—Furosemide—dilated cardiomyopathy	0.0363	0.0363	CcSEcCtD
Gadoteridol—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0346	0.0346	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.0222	0.0222	CcSEcCtD
Gadoteridol—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0221	0.0221	CcSEcCtD
Gadoteridol—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0216	0.0216	CcSEcCtD
Gadoteridol—Wheezing—Lisinopril—dilated cardiomyopathy	0.0216	0.0216	CcSEcCtD
Gadoteridol—Malaise—Spironolactone—dilated cardiomyopathy	0.0214	0.0214	CcSEcCtD
Gadoteridol—Fluid retention—Lisinopril—dilated cardiomyopathy	0.0211	0.0211	CcSEcCtD
Gadoteridol—Discomfort—Spironolactone—dilated cardiomyopathy	0.02	0.02	CcSEcCtD
Gadoteridol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0194	0.0194	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0167	0.0167	CcSEcCtD
Gadoteridol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.016	0.016	CcSEcCtD
Gadoteridol—Sweating—Furosemide—dilated cardiomyopathy	0.0159	0.0159	CcSEcCtD
Gadoteridol—Face oedema—Lisinopril—dilated cardiomyopathy	0.0156	0.0156	CcSEcCtD
Gadoteridol—Urticaria—Spironolactone—dilated cardiomyopathy	0.0154	0.0154	CcSEcCtD
Gadoteridol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0153	0.0153	CcSEcCtD
Gadoteridol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0153	0.0153	CcSEcCtD
Gadoteridol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0143	0.0143	CcSEcCtD
Gadoteridol—Tinnitus—Furosemide—dilated cardiomyopathy	0.0139	0.0139	CcSEcCtD
Gadoteridol—Pruritus—Spironolactone—dilated cardiomyopathy	0.0137	0.0137	CcSEcCtD
Gadoteridol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0133	0.0133	CcSEcCtD
Gadoteridol—Erythema—Furosemide—dilated cardiomyopathy	0.0129	0.0129	CcSEcCtD
Gadoteridol—Dizziness—Spironolactone—dilated cardiomyopathy	0.0128	0.0128	CcSEcCtD
Gadoteridol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0127	0.0127	CcSEcCtD
Gadoteridol—Vomiting—Spironolactone—dilated cardiomyopathy	0.0123	0.0123	CcSEcCtD
Gadoteridol—Rash—Spironolactone—dilated cardiomyopathy	0.0122	0.0122	CcSEcCtD
Gadoteridol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0122	0.0122	CcSEcCtD
Gadoteridol—Headache—Spironolactone—dilated cardiomyopathy	0.0122	0.0122	CcSEcCtD
Gadoteridol—Sweating—Lisinopril—dilated cardiomyopathy	0.0119	0.0119	CcSEcCtD
Gadoteridol—Nausea—Spironolactone—dilated cardiomyopathy	0.0115	0.0115	CcSEcCtD
Gadoteridol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.0114	0.0114	CcSEcCtD
Gadoteridol—Rhinitis—Lisinopril—dilated cardiomyopathy	0.0112	0.0112	CcSEcCtD
Gadoteridol—Dry mouth—Furosemide—dilated cardiomyopathy	0.0108	0.0108	CcSEcCtD
Gadoteridol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0106	0.0106	CcSEcCtD
Gadoteridol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Gadoteridol—Shock—Furosemide—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Gadoteridol—Flushing—Lisinopril—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Gadoteridol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0102	0.0102	CcSEcCtD
Gadoteridol—Hypotension—Furosemide—dilated cardiomyopathy	0.00987	0.00987	CcSEcCtD
Gadoteridol—Erythema—Lisinopril—dilated cardiomyopathy	0.00971	0.00971	CcSEcCtD
Gadoteridol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00951	0.00951	CcSEcCtD
Gadoteridol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00948	0.00948	CcSEcCtD
Gadoteridol—Tremor—Lisinopril—dilated cardiomyopathy	0.0091	0.0091	CcSEcCtD
Gadoteridol—Pain—Furosemide—dilated cardiomyopathy	0.00903	0.00903	CcSEcCtD
Gadoteridol—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00901	0.00901	CcSEcCtD
Gadoteridol—Malaise—Lisinopril—dilated cardiomyopathy	0.00876	0.00876	CcSEcCtD
Gadoteridol—Syncope—Lisinopril—dilated cardiomyopathy	0.00871	0.00871	CcSEcCtD
Gadoteridol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0087	0.0087	CcSEcCtD
Gadoteridol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00853	0.00853	CcSEcCtD
Gadoteridol—Cough—Lisinopril—dilated cardiomyopathy	0.00847	0.00847	CcSEcCtD
Gadoteridol—Urticaria—Furosemide—dilated cardiomyopathy	0.00839	0.00839	CcSEcCtD
Gadoteridol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00835	0.00835	CcSEcCtD
Gadoteridol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00835	0.00835	CcSEcCtD
Gadoteridol—Chest pain—Lisinopril—dilated cardiomyopathy	0.00827	0.00827	CcSEcCtD
Gadoteridol—Anxiety—Lisinopril—dilated cardiomyopathy	0.00824	0.00824	CcSEcCtD
Gadoteridol—Discomfort—Lisinopril—dilated cardiomyopathy	0.00817	0.00817	CcSEcCtD
Gadoteridol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00808	0.00808	CcSEcCtD
Gadoteridol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00792	0.00792	CcSEcCtD
Gadoteridol—Oedema—Lisinopril—dilated cardiomyopathy	0.00792	0.00792	CcSEcCtD
Gadoteridol—Shock—Lisinopril—dilated cardiomyopathy	0.0078	0.0078	CcSEcCtD
Gadoteridol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00778	0.00778	CcSEcCtD
Gadoteridol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00766	0.00766	CcSEcCtD
Gadoteridol—Pruritus—Furosemide—dilated cardiomyopathy	0.00747	0.00747	CcSEcCtD
Gadoteridol—Hypotension—Lisinopril—dilated cardiomyopathy	0.0074	0.0074	CcSEcCtD
Gadoteridol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00723	0.00723	CcSEcCtD
Gadoteridol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00712	0.00712	CcSEcCtD
Gadoteridol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00706	0.00706	CcSEcCtD
Gadoteridol—Dizziness—Furosemide—dilated cardiomyopathy	0.00698	0.00698	CcSEcCtD
Gadoteridol—Pain—Lisinopril—dilated cardiomyopathy	0.00678	0.00678	CcSEcCtD
Gadoteridol—Vomiting—Furosemide—dilated cardiomyopathy	0.00672	0.00672	CcSEcCtD
Gadoteridol—Rash—Furosemide—dilated cardiomyopathy	0.00666	0.00666	CcSEcCtD
Gadoteridol—Dermatitis—Furosemide—dilated cardiomyopathy	0.00665	0.00665	CcSEcCtD
Gadoteridol—Headache—Furosemide—dilated cardiomyopathy	0.00662	0.00662	CcSEcCtD
Gadoteridol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00653	0.00653	CcSEcCtD
Gadoteridol—Urticaria—Lisinopril—dilated cardiomyopathy	0.0063	0.0063	CcSEcCtD
Gadoteridol—Nausea—Furosemide—dilated cardiomyopathy	0.00627	0.00627	CcSEcCtD
Gadoteridol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00626	0.00626	CcSEcCtD
Gadoteridol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00626	0.00626	CcSEcCtD
Gadoteridol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00584	0.00584	CcSEcCtD
Gadoteridol—Pruritus—Lisinopril—dilated cardiomyopathy	0.00561	0.00561	CcSEcCtD
Gadoteridol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00542	0.00542	CcSEcCtD
Gadoteridol—Dizziness—Lisinopril—dilated cardiomyopathy	0.00524	0.00524	CcSEcCtD
Gadoteridol—Vomiting—Lisinopril—dilated cardiomyopathy	0.00504	0.00504	CcSEcCtD
Gadoteridol—Rash—Lisinopril—dilated cardiomyopathy	0.005	0.005	CcSEcCtD
Gadoteridol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00499	0.00499	CcSEcCtD
Gadoteridol—Headache—Lisinopril—dilated cardiomyopathy	0.00496	0.00496	CcSEcCtD
Gadoteridol—Nausea—Lisinopril—dilated cardiomyopathy	0.00471	0.00471	CcSEcCtD
